Chronic myelogenous leukemia presenting with bilateral optic disc neovascularization

Can J Ophthalmol. 2014 Jun;49(3):e68-70. doi: 10.1016/j.jcjo.2014.02.013.

Authors

David R P Almeida¹, Eric K Chin², Lorna W Grant²

Affiliations

¹ University of Iowa Hospitals & Clinics, Iowa City, Iowa. Electronic address: dalmeida@evolation-medical.com.
² University of Iowa Hospitals & Clinics, Iowa City, Iowa.

PMID: 24862787
DOI: 10.1016/j.jcjo.2014.02.013

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Combined Modality Therapy
Dasatinib
Fluorescein Angiography
Humans
In Situ Hybridization, Fluorescence
Laser Coagulation
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
Leukocyte Count
Leukocytosis
Magnetic Resonance Imaging
Male
Middle Aged
Optic Disk / blood supply*
Protein Kinase Inhibitors / therapeutic use
Pyrimidines / therapeutic use
Retinal Neovascularization / diagnosis*
Retinal Neovascularization / therapy
Thiazoles / therapeutic use
Visual Acuity
Vitrectomy

Substances

Protein Kinase Inhibitors
Pyrimidines
Thiazoles
Dasatinib